Global bibliometric analysis of traditional Chinese medicine regulating gut microbiota in the treatment of diabetes from 2004 to 2024
ObjectivesThe therapeutic efficacy of Traditional Chinese Medicine (TCM) in modulating gut microbiota for diabetes treatment has garnered increasing scholarly attention. This study aims to meticulously examine current research trajectories and focal areas from 2004 to 2024, providing a foundational...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1533984/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832590801582948352 |
|---|---|
| author | Jieling Liang Xiaojuan Lin Xin Liao Xi Chen Ying Zhou Lin Zhang Yunyun Qin Haoru Meng Zhongwen Feng |
| author_facet | Jieling Liang Xiaojuan Lin Xin Liao Xi Chen Ying Zhou Lin Zhang Yunyun Qin Haoru Meng Zhongwen Feng |
| author_sort | Jieling Liang |
| collection | DOAJ |
| description | ObjectivesThe therapeutic efficacy of Traditional Chinese Medicine (TCM) in modulating gut microbiota for diabetes treatment has garnered increasing scholarly attention. This study aims to meticulously examine current research trajectories and focal areas from 2004 to 2024, providing a foundational framework for future inquiries.MethodsA comprehensive search of documents published between 2004 and 2024 was conducted using the Web of Science database. The resulting data were analyzed and visualized using R software, VOSviewer, and CiteSpace.ResultsThe study included a total of 751 documents. From 2004 to 2022, the number of annual publications showed a continuous upward trend (2004: n = 1 to 2022: n = 159), and the number of publications in 2023 (n = 141) decreased slightly from the previous year. China emerged as the leading country in terms of article publications (n = 430). Additionally, the United States played a prominent role in international research collaborations. Frontiers in Pharmacology (n = 31) was the most frequently published journal, while Nature (n = 1,147) achieved the highest citation count. Key identified keywords included obesity, insulin resistance, inflammation, and oxidative stress.ConclusionThree key research focuses in this domain include: the therapeutic effects of active constituents in TCM on diabetes via gut microbiota modulation, the underlying mechanisms through which TCM influences gut microbiota in diabetes management, and the targeted regulation of specific gut bacterial populations by TCM in the treatment of diabetes. |
| format | Article |
| id | doaj-art-2d2a12e6dcec4667b2630c4be7e2314f |
| institution | Kabale University |
| issn | 1663-9812 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj-art-2d2a12e6dcec4667b2630c4be7e2314f2025-01-23T06:56:35ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-01-011610.3389/fphar.2025.15339841533984Global bibliometric analysis of traditional Chinese medicine regulating gut microbiota in the treatment of diabetes from 2004 to 2024Jieling Liang0Xiaojuan Lin1Xin Liao2Xi Chen3Ying Zhou4Lin Zhang5Yunyun Qin6Haoru Meng7Zhongwen Feng8Department of Pharmacy, Guilin Hospital of the Second Xiangya Hospital, Central South University, Guilin, ChinaDepartment of Pharmacy, Guangxi Academy of Medical Sciences and the People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, ChinaDepartment of Pharmacy, Guangxi Academy of Medical Sciences and the People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, ChinaDepartment of Pharmacy, Guilin Hospital of the Second Xiangya Hospital, Central South University, Guilin, ChinaDepartment of Pharmacy, Guilin Hospital of the Second Xiangya Hospital, Central South University, Guilin, ChinaDepartment of Pharmacy, Guangxi Academy of Medical Sciences and the People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, ChinaDepartment of Pharmacy, Guangxi Academy of Medical Sciences and the People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, ChinaPhase 1 Clinical Trial Laboratory, Guangxi Academy of Medical Sciences and the People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, ChinaDepartment of Pharmacy, Guangxi Academy of Medical Sciences and the People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, ChinaObjectivesThe therapeutic efficacy of Traditional Chinese Medicine (TCM) in modulating gut microbiota for diabetes treatment has garnered increasing scholarly attention. This study aims to meticulously examine current research trajectories and focal areas from 2004 to 2024, providing a foundational framework for future inquiries.MethodsA comprehensive search of documents published between 2004 and 2024 was conducted using the Web of Science database. The resulting data were analyzed and visualized using R software, VOSviewer, and CiteSpace.ResultsThe study included a total of 751 documents. From 2004 to 2022, the number of annual publications showed a continuous upward trend (2004: n = 1 to 2022: n = 159), and the number of publications in 2023 (n = 141) decreased slightly from the previous year. China emerged as the leading country in terms of article publications (n = 430). Additionally, the United States played a prominent role in international research collaborations. Frontiers in Pharmacology (n = 31) was the most frequently published journal, while Nature (n = 1,147) achieved the highest citation count. Key identified keywords included obesity, insulin resistance, inflammation, and oxidative stress.ConclusionThree key research focuses in this domain include: the therapeutic effects of active constituents in TCM on diabetes via gut microbiota modulation, the underlying mechanisms through which TCM influences gut microbiota in diabetes management, and the targeted regulation of specific gut bacterial populations by TCM in the treatment of diabetes.https://www.frontiersin.org/articles/10.3389/fphar.2025.1533984/fulltraditional Chinese medicinediabetesgut microbiotaactive constituentsmechanism |
| spellingShingle | Jieling Liang Xiaojuan Lin Xin Liao Xi Chen Ying Zhou Lin Zhang Yunyun Qin Haoru Meng Zhongwen Feng Global bibliometric analysis of traditional Chinese medicine regulating gut microbiota in the treatment of diabetes from 2004 to 2024 Frontiers in Pharmacology traditional Chinese medicine diabetes gut microbiota active constituents mechanism |
| title | Global bibliometric analysis of traditional Chinese medicine regulating gut microbiota in the treatment of diabetes from 2004 to 2024 |
| title_full | Global bibliometric analysis of traditional Chinese medicine regulating gut microbiota in the treatment of diabetes from 2004 to 2024 |
| title_fullStr | Global bibliometric analysis of traditional Chinese medicine regulating gut microbiota in the treatment of diabetes from 2004 to 2024 |
| title_full_unstemmed | Global bibliometric analysis of traditional Chinese medicine regulating gut microbiota in the treatment of diabetes from 2004 to 2024 |
| title_short | Global bibliometric analysis of traditional Chinese medicine regulating gut microbiota in the treatment of diabetes from 2004 to 2024 |
| title_sort | global bibliometric analysis of traditional chinese medicine regulating gut microbiota in the treatment of diabetes from 2004 to 2024 |
| topic | traditional Chinese medicine diabetes gut microbiota active constituents mechanism |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2025.1533984/full |
| work_keys_str_mv | AT jielingliang globalbibliometricanalysisoftraditionalchinesemedicineregulatinggutmicrobiotainthetreatmentofdiabetesfrom2004to2024 AT xiaojuanlin globalbibliometricanalysisoftraditionalchinesemedicineregulatinggutmicrobiotainthetreatmentofdiabetesfrom2004to2024 AT xinliao globalbibliometricanalysisoftraditionalchinesemedicineregulatinggutmicrobiotainthetreatmentofdiabetesfrom2004to2024 AT xichen globalbibliometricanalysisoftraditionalchinesemedicineregulatinggutmicrobiotainthetreatmentofdiabetesfrom2004to2024 AT yingzhou globalbibliometricanalysisoftraditionalchinesemedicineregulatinggutmicrobiotainthetreatmentofdiabetesfrom2004to2024 AT linzhang globalbibliometricanalysisoftraditionalchinesemedicineregulatinggutmicrobiotainthetreatmentofdiabetesfrom2004to2024 AT yunyunqin globalbibliometricanalysisoftraditionalchinesemedicineregulatinggutmicrobiotainthetreatmentofdiabetesfrom2004to2024 AT haorumeng globalbibliometricanalysisoftraditionalchinesemedicineregulatinggutmicrobiotainthetreatmentofdiabetesfrom2004to2024 AT zhongwenfeng globalbibliometricanalysisoftraditionalchinesemedicineregulatinggutmicrobiotainthetreatmentofdiabetesfrom2004to2024 |